Next Article in Journal / Special Issue
To Die or to Survive, a Fatal Question for the Destiny of Prostate Cancer Cells after Androgen Deprivation Therapy
Previous Article in Journal
Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitro
Previous Article in Special Issue
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Cancers 2011, 3(2), 1480-1497; doi:10.3390/cancers3021480
Review

Role of Methionine Adenosyltransferase Genes in Hepatocarcinogenesis

1
, 2
 and 1,*
Received: 16 December 2010; in revised form: 27 January 2011 / Accepted: 30 January 2011 / Published: 24 March 2011
(This article belongs to the Special Issue Cell Death and Cancer)
View Full-Text   |   Download PDF [272 KB, uploaded 24 March 2011]   |   Browse Figures
Abstract: Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. Detection of HCC can be difficult, as most of the patients who develop this tumor have no symptoms other than those related to their longstanding liver disease. There is an urgent need to understand the molecular mechanisms that are responsible for the development of this disease so that appropriate therapies can be designed. Methionine adenosyltransferase (MAT) is an essential enzyme required for the biosynthesis of S-adenosylmethionine (AdoMet), an important methyl donor in the cell. Alterations in the expression of MAT genes and a decline in AdoMet biosynthesis are known to be associated with liver injury, cirrhosis and HCC. This review focuses on the role of MAT genes in HCC development and the scope for therapeutic strategies using these genes.
Keywords: methionine adenosyltransferase (MAT); hepatocellular carcinoma (HCC); S-adenosylmethionine (AdoMet) methionine adenosyltransferase (MAT); hepatocellular carcinoma (HCC); S-adenosylmethionine (AdoMet)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ramani, K.; Mato, J.M.; Lu, S.C. Role of Methionine Adenosyltransferase Genes in Hepatocarcinogenesis. Cancers 2011, 3, 1480-1497.

AMA Style

Ramani K, Mato JM, Lu SC. Role of Methionine Adenosyltransferase Genes in Hepatocarcinogenesis. Cancers. 2011; 3(2):1480-1497.

Chicago/Turabian Style

Ramani, Komal; Mato, José M.; Lu, Shelly C. 2011. "Role of Methionine Adenosyltransferase Genes in Hepatocarcinogenesis." Cancers 3, no. 2: 1480-1497.


Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert